KPC Pharmaceuticals, Inc.

SSE:600422.SS

15.47 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 8,401.4477,703.1218,282.0638,253.5337,717.0878,119.9637,101.9785,852.2875,100.5974,915.6864,120.5093,584.2953,016.0222,434.0081,817.2381,434.9091,310.9311,290.2581,146.5531,207.635673.675665.34504.858488.24511.359454.248395.154272.209
Cost of Revenue 4,750.1974,293.4724,843.694,844.7774,333.9944,167.2283,559.0963,221.5643,128.5653,219.832,886.792,539.4352,058.2611,712.6811,228.245929.147857.797857.187828.15932296.849296.946279.589285.632316.512300.127239.477172.722
Gross Profit 3,651.2513,409.653,438.3733,408.7553,383.0933,952.7353,542.8812,630.7231,972.0321,695.8561,233.7191,044.86957.761721.327588.993505.762453.134433.071318.403275.635376.826368.394225.268202.608194.847154.121155.67799.487
Gross Profit Ratio 0.4350.4430.4150.4130.4380.4870.4990.450.3870.3450.2990.2920.3180.2960.3240.3520.3460.3360.2780.2280.5590.5540.4460.4150.3810.3390.3940.365
Reseach & Development Expenses 106.76171.26369.651100.517128.44983.51277.11463.1988.47544.02515.2818.81817.0048.868.8450000000000000
General & Administrative Expenses 87.82576.78882.588118.258120.166102.27499.38289.20173.82267.74868.09966.76147.58942.59135.01397.18497.46394.91385.324112.18673.45791.44958.30562.68150.03843.81451.10636.661
Selling & Marketing Expenses 1,817.7542,072.4512,432.5682,373.4552,351.1972,978.5482,664.9571,806.3171,183.119881.587652.54542.139541.394394.488338.38293.758275.206260.094195.104239.605193.09180.325112.01495.13684.89271.61361.70640.568
SG&A 2,538.8962,791.0422,515.1572,491.7132,471.3633,080.8222,764.3391,895.5181,256.941949.335720.639608.9588.983437.079373.394390.941372.67355.007280.428351.791266.546271.774170.319157.817134.931115.427112.81377.229
Other Expenses 711.363-21.151239.233240.39238.809228.602-2.676-3.9857.42841.07726.56617.95521.87312.616.1555.3184.6875.323-2.414-3.0073.0010.5524.8922.8375.4997.2594.9247.61
Operating Expenses 2,723.7042,841.1542,824.0422,832.622,838.6213,392.9363,110.2212,189.6331,565.31,212.087894.026754.793721.285542.531459.41399.065380.16361.228284.349356.224271.661276.711172.972160.454137.102117.616114.20278.178
Operating Income 927.547568.496497.148634.047540.83539.803419.814411.911424.307465.419339.539266.053222.173163.189111.21274.59738.54931.0918.225-84.093113.27893.67861.45546.72751.94329.76932.71316.229
Operating Income Ratio 0.110.0740.060.0770.070.0660.0590.070.0830.0950.0820.0740.0740.0670.0610.0520.0290.0240.016-0.070.1680.1410.1220.0960.1020.0660.0830.06
Total Other Income Expenses Net 7.024-4.876-19.861-2.758-0.3444.631-2.676-457.21240.49636.82517.57619.79411.9616.151-5.3-30-35.659-3.245-4.2710.83-1.8583.1262.9395.0665.8674.7787.367
Income Before Tax 934.57563.62477.287631.289540.487544.433417.138407.931480.927505.915365.951283.629241.967175.15117.36379.63742.97536.18414.979-88.364114.10991.8264.58249.66557.00935.63637.49123.596
Income Before Tax Ratio 0.1110.0730.0580.0760.070.0670.0590.070.0940.1030.0890.0790.080.0720.0650.0550.0330.0280.013-0.0730.1690.1380.1280.1020.1110.0780.0950.087
Income Tax Expense 183.35109.47791.827118.07578.30476.67875.45272.64471.40874.658.25647.98540.78629.69418.68612.6836.7695.2327.50212.4716.63711.08111.494.6397.5654.0074.2223.079
Net Income 648.081444.68383.184507.668456.856454.309335.536330.097407.256420.851292.237231.623181.75130.12385.57858.32332.11829.06917.83-44.56691.77970.39344.58838.32235.17923.89624.08311.016
Net Income Ratio 0.0770.0580.0460.0620.0590.0560.0470.0560.080.0860.0710.0650.060.0530.0470.0410.0250.0230.016-0.0370.1360.1060.0880.0780.0690.0530.0610.04
EPS 0.860.590.510.670.60.60.440.420.520.530.370.360.290.210.140.0930.0510.0460.004-0.0710.0780.0860.0550.0470.0480.0380.0380.018
EPS Diluted 0.860.590.510.670.60.60.440.420.520.530.370.360.290.210.140.0930.0510.0460.004-0.0710.0780.0860.0550.0470.0480.0380.0380.018
EBITDA 1,156.957801.815726.818870.948757.047727.355558.764548.023598.383610.561464.969348.782297.92223.008161.902127.10996.41889.92965.091-46.885115.323115.28979.20967.71182.11548.47441.47521.309
EBITDA Ratio 0.1380.1040.0880.1060.0980.090.0790.0940.1170.1240.1130.0970.0990.0920.0890.0890.0740.070.057-0.0390.1710.1730.1570.1390.1610.1070.1050.078